Pluto Bioinformatics

GSE58966: GATA2 shRNA Expression in Castration Resistant Prostate Cancer Cell Lines

Bulk RNA sequencing

The transcription factor GATA2 regulates chemotherapy resistance in prostate cancer. We report a novel GATA2 transcriptional program that has implications for chemotherapy resistance disease and aggressiveness in castration resistant prostate cancer. SOURCE: Josep Domingo-Domenech (josep.domingo-domenech@mssm.edu) - Mount Sinai School of Medicine